General Information of the Compound
| Compound ID |
CP0030579
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1R,2S)-(-)-2-phenylcyclopropylamine
Show/Hide
|
||||||||||||||||||
| Synonyms |
(+)-(R)-Tranylcypromine
(+)-Tranylcypromine
(+)-trans-2-Phenylcyclopropylamine
(-)-Tranylcypromine
(1R)-2-phenylcyclopropan-1-amine
(1R,2R)-2-phenylcyclopropan-1-amine
(1R,2S)-2-phenylcyclopropan-1-amine
(1R,2S)-2-phenylcyclopropanamine
(1S)-2-phenylcyclopropan-1-amine
(1S,2R)-2-phenylcyclopropan-1-amine
(1S,2S)-2-phenylcyclopropan-1-amine
(2S)-2-phenylcyclopropan-1-amine
2-Phenylcyclopropanamine
2-phenylcyclopropan-1-amine
Allphar Brand of Tranylcypromine Sulfate
Cyclopropanamine, 2-phenyl-, (1R-trans)-(9CI)
D-Tranylcypromine
Dl-Tranylcypromine
Esparma Brand of Tranylcypromine Sulfate
GJZ
GlaxoSmithKline Brand of Tranylcypromine Sulfate
Goldshield Brand of Tranylcypromine Sulfate
Jatrosom
Jatrosom (TN)
L-Tranylcypromine
Link Brand of Tranylcypromine Sulfate
Parmodalin (TN)
Parnate
Parnate (TN)
Parnitene
Parstelin (TN)
Racemic Tranylcypromine
SKF 385
SKF Trans-385
Sicoton (TN)
SmithKline Brand of Tranylcypromine Sulfate
Sulfate, Tranylcypromine
Tranilcipromina
Tranilcipromina [INN-Spanish]
Trans 2 Phenylcyclopropylamine
Trans-(-)-2-Phenylcyclopropanamine
Trans-2-Phenylcyclopropylamine
Trans-DL-2-Phenylcyclopropylamine
Transamine
Transamine (TN)
Transapin (TN)
Tranylcypromine
Tranylcypromine (INN)
Tranylcypromine [INN:BAN]
Tranylcyprominum
Tranylcyprominum [INN-Latin]
Tylciprine (TN)
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C9H11N
|
||||||||||||||||||
| Molecular Weight |
133.194
|
||||||||||||||||||
| Canonical SMILES |
N[C@@H]1C[C@H]1c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C9H11N/c10-9-6-8(9)7-4-2-1-3-5-7/h1-5,8-9H,6,10H2/t8-,9+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
AELCINSCMGFISI-DTWKUNHWSA-N
|
||||||||||||||||||
| CAS |
3721-26-4
3721-28-6
95-62-5
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound